Completed PHASE4 INTERVENTIONAL 1-arm NCT01346982

Drug Interactions Between Silimarine and Darunavir/Ritonavir

Drug Interactions Between Silimarine And Darunavir/Ritonavir

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Conditions HIV

Interventions Silimarine

Updated 6 times since 2017 Last updated: Nov 11, 2019 Started: Mar 31, 2011 Primary completion: Jul 31, 2011 Completion: Jul 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates HIV and is currently completed. Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau leads this study, which shows 6 recorded versions since 2011 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Dec 2019 — Jan 2021 [monthly]

Completed PHASE4
Jun 2018 — Dec 2019 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Mar 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
IrsiCaixa

Data source: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Badalona, Spain